Healthcare execs’ No. 1 growth strategy for 2020: Buy or merge, Capital One finds

The plurality (41 percent) of healthcare executives said buying or merging with a business is their preferred growth strategy for next year, according to a survey from Capital One.

Advertisement

For the survey, Capital One asked 123 healthcare executives across the industry about their 12-month outlook. When it comes to growth, second to merging and buying was revitalizing and updating existing offerings, with 30 percent of executives saying it was a top growth strategy for them. That’s up from 21 percent who said the same thing last year.

David Varhol, senior managing director at Capital One Healthcare, said in a prepared statement that “the uptick in executives looking to update existing offerings as a means for growth may indicate that the industry is already adjusting to [growing] pressures.”

Overall, two-thirds of healthcare executives think their business performance will be better in the coming year than in the last 12 months, according to the survey. Only 4 percent expect overall business performance to drop next year.

More articles on strategy:
Prisma eliminates 2 president roles
Riley Children’s strikes partnership in Beirut
U of Louisville’s first change to KentuckyOne hospitals after deal: Their names

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Strategy

Advertisement

Comments are closed.